Another 16-week phase 2 trial in subjects with T2D and BMI 2550 kg/m 2 treated with survodutide 0.3, 0.9, 1.8, 2.7 mg weekly, 1.2 mg and 1.8 mg twice weekly, compared to semaglutide 1.0 mg weekly or placebo shows mean HbA1c percentage point reductions of 0.9, 1.5, 1.7, 1.6, 1.6, 1.7, 1.5, and 0.2, respectively, as well as mean body weight reductions significantly greater than placebo at all treatment doses, the highest being 8.7% for the 1.8 mg twice a week dose (97)
Supporting Liver Function and Detoxification The liver plays a vital role in detoxifying the body and eliminating harmful substances
A standard 3.2 mg KLOW dose contains only 400 mcg of full-length TB-4
Fremaux, J
Every skin colour looks beautiful if you have a healthy, clear and even tone skin